{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:46:42Z","timestamp":1778600802901,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114053","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T12:43:28Z","timestamp":1737204208000},"page":"114053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The natural product-derived JM-9 alleviates high-fat diet-induced fatty liver in mice by targeting MD2"],"prefix":"10.1016","volume":"148","author":[{"given":"Leiming","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangsheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaishou","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9969-2232","authenticated-orcid":false,"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2025.114053_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.intimp.2025.114053_b0010","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2025.114053_b0015","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.114053_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.114053_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040476","article-title":"Innate immunity and MASLD","volume":"14","author":"Meyer","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2025.114053_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114291","article-title":"Toll-like receptor 4 (TLR4) inhibitors: current research and prospective","volume":"235","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2025.114053_b0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2003.08.003","article-title":"Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex","volume":"100","author":"Fujihara","year":"2003","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2025.114053_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.777","article-title":"MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease","volume":"12","author":"Luo","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114053_b0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/1040638717728545","article-title":"Pattern-recognition receptors: signaling pathways and dysregulation in canine chronic enteropathies-brief review","volume":"29","author":"Heilmann","year":"2017","journal-title":"J. Vet. Diagn. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2025.114053_b0055","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00163.2009","article-title":"Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice","volume":"300","author":"Csak","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"31","key":"10.1016\/j.intimp.2025.114053_b0060","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2306399120","article-title":"Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2","volume":"120","author":"Bai","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.intimp.2025.114053_b0065","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/bph.15999","article-title":"Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2)","volume":"180","author":"Zhu","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114053_b0070","doi-asserted-by":"crossref","unstructured":"I. Menu Neelaka Molagoda, W. Arachchilage Hasitha Maduranga Karunarathne, M.H. Lee, C.H. Kang, K. Tae Lee, Y. Hyun Choi, S. Lee, G.Y. Kim, Acertannin attenuates LPS-induced inflammation by interrupting the binding of LPS to the TLR4\/MD2 complex and activating Nrf2-mediated HO-1 activation, Int. Immunopharmacol. 113(Pt A) (2022) 109344.","DOI":"10.1016\/j.intimp.2022.109344"},{"key":"10.1016\/j.intimp.2025.114053_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152997","article-title":"Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury","volume":"63","author":"Chen","year":"2019","journal-title":"Phytomedicine"},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.114053_b0080","article-title":"Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88","volume":"124","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114053_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115289","article-title":"Novel O-benzylcinnamic acid derivative L26 treats acute lung injury in mice by MD-2","volume":"252","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114053_b0090","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29881","article-title":"Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis","volume":"68","author":"Qu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114053_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/783976","article-title":"Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation","author":"Fon Tacer","year":"2011","journal-title":"J Lipids"},{"key":"10.1016\/j.intimp.2025.114053_b0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.intimp.2025.114053_b0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nbd.2018.12.007","article-title":"Cinnamic acid activates PPARalpha to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer's disease mouse model","volume":"124","author":"Chandra","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1476-5381.1992.tb14487.x","article-title":"Determination of alpha 1-adrenoceptor subtype selectivity by [3H]-prazosin displacement studies in guinea-pig cerebral cortex and rat spleen membranes","volume":"107","author":"Veenstra","year":"1992","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114053_b0115","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114053_b0120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2025.114053_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.intimp.2025.114053_b0130","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-556-0","article-title":"Li, PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets","author":"Zheng","year":"2024","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15548627.2019.1596488","article-title":"Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model","volume":"16","author":"Luo","year":"2020","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.intimp.2025.114053_b0140","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.123.065603","article-title":"USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart","volume":"149","author":"Xie","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2025.114053_b0145","first-page":"H725","article-title":"Cardiac alpha1A-adrenergic receptors: emerging protective roles in cardiovascular diseases","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/pr.112.007203","article-title":"Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance","volume":"66","author":"O'Connell","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2025.114053_b0155","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.4c00411","article-title":"Blocking alpha(1) adrenergic receptor as a novel target for treating Alzheimer's disease","author":"Pan","year":"2024","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.intimp.2025.114053_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115660","article-title":"Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice","volume":"168","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2025.114053_b0165","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1194\/jlr.R087510","article-title":"Muscle and adipose tissue insulin resistance: malady without mechanism?","volume":"60","author":"Fazakerley","year":"2019","journal-title":"J. Lipid Res."},{"issue":"19","key":"10.1016\/j.intimp.2025.114053_b0170","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14607","article-title":"Mechanisms of muscle insulin resistance and the cross-talk with liver and adipose tissue","volume":"8","author":"da Silva Rosa","year":"2020","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2025.114053_b0180","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0185","article-title":"MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.114053_b0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbadis.2017.09.026","article-title":"Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis","volume":"1864","author":"Fang","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.intimp.2025.114053_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.786599","article-title":"High-fat diet-induced renal proximal tubular inflammatory injury: emerging risk factor of chronic kidney disease","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2025.114053_b0200","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2025.114053_b0205","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jcmm.13395","article-title":"Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell Mol. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:58:02Z","timestamp":1740617882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"alternative-id":["S1567576925000426"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114053","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The natural product-derived JM-9 alleviates high-fat diet-induced fatty liver in mice by targeting MD2","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114053"}}